Dispute over competition regulation seen as debate over democracy
The link between market competition and democracy is creating an intellectual tug-of-war between progressives and their conservative counterparts.
The great fashion-model conspiracy
The antitrust profession thinks of labor cases as a recent policy innovation. But on the important topic of wage collusion, they date back several decades, at least to the Federal Trade Commission’s memorable case against the great fashion-model conspiracy of 1993.
Current Issue: 881
Antitrust officials in more than 30 states begin to look at Anthem-Cigna and Aetna-Humana deals
The following article first appeared on Sept. 23 on MLex. For more information on MLex, including getting access to its exclusive content, please contact sales@mlex.com.
SMARTER Act moves forward on mostly party-line vote
The House Judiciary Committee approved the Standard Merger and Acquisition Reviews Through Equal Rules Act (SMARTER Act), legislation that would revise merger review policies at the Federal Trade...
Local regulations on Uber, AirBnB should be tailored, Ramirez says
The following article first appeared on Oct. 2 on MLex. For more information on MLex, including getting access to its exclusive content, please contact sales@mlex.com.
FTC officials head to Utah for consumer protection summit
Federal Trade Commission officials are joining with their Utah counterparts for a summit on combating consumer scams—a problem that has been proliferating in that state.
Neil Averitt commentary: A simple primer for dealing with a landmark new ruling
The recent Supreme Court ruling that the Harvard Law Record has called antitrust’s Brown v. Board of Education is causing consternation all over the country, and states and professional boards are...
A look behind the scenes at the Expedia merger approval
During the Justice Department’s recent review of Expedia’s proposed acquisition of Orbitz, one consumer group, along with some senior lawmakers, urged the watchdog to block what they saw as a deal...
FTC turning up the heat on homeopathic drugs
The Federal Trade Commission is preparing to clamp down on the advertising claims made by manufacturers of homeopathic drugs, an action that could cause a major shakeup in a multibillion-dollar industry.